Follow the 티디에스팜 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 티디에스팜 has published 16 insider filings. The latest transaction was reported on 24 June 2026 (Other). Among the most active insiders: 김철준. All data is openly available.
16
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
티디에스팜 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.